EPR 2010
EPR 2010
批准号:
7912542
负责人:
BALARAMAN KALYANARAMAN
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2011-03-31
关键词:
ArtsAsiaAustraliaBiologyBiomedical ResearchBiophysicsChemicalsChemistryChicagoCollaborationsCommunitiesCountryDevelopmentEducational workshopEffectivenessElectron Spin Resonance SpectroscopyEquilibriumEuropeFacultyFundingFutureGeographic LocationsHispanicsImageImaging technologyInstitutionInternationalJointsKnowledgeLatin AmericaMagnetic ResonanceMalignant NeoplasmsMethodologyMinorityNational Cancer InstituteOxidation-ReductionParticipantPhysiciansPhysiologyPostdoctoral FellowPuerto RicoRadiobiologyRare DiseasesResearchResearch ActivityResearch PersonnelScienceScientistSignal TransductionSouth AmericaSpectrum AnalysisSpin LabelsSpin TrappingSystemTechniquesTechnologyTherapeuticUnited States National Institutes of HealthUniversitiesWisconsinWomanbasebiological systemscollegegraduate studentin vivoinstrumentationmedical schoolsmeetingsprogramspublic health relevancestructural biologysymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): EPR 2010 will be a joint conference of the 14th In Vivo EPR Spectroscopy and Imaging meeting and the 11th International EPR Spin Trapping/Spin Labeling meeting. It will be held May 2-6, 2010 at the Condado Plaza Hotel, San Juan, Puerto Rico. The meeting is sponsored by the Department of Chemistry at the University of Puerto Rico at Humacao, and the Department of Biophysics at the Medical College of Wisconsin. The Conference is an international workshop that brings together a community of scientists who apply the technique of electron paramagnetic resonance (EPR) to problems intimately related to imaging, structural biology, biomedicine, and therapy. The primary focus of the meeting will be on the use of magnetic resonance technology to investigate the fundamental mechanisms related to technology, imaging, structural biology, spin trap/spin probe syntheses, oxidative cell signaling, redox biology, biomedicine, and therapeutics. Sessions will provide a balance between studies of chemical biological systems and advances in techniques and methodology. This will help strengthen the program and promote the effectiveness of science in the U.S. and around the world. In addition to other invited institutions, all of the NIH-funded EPR centers will participate: National Biomedical EPR Center (Medical College of Wisconsin, Milwaukee, WI), EPR Center for the Study of Viable Systems (Dartmouth College, Hanover, NH), National Biomedical Center for Advanced ESR Technology (Cornell University, Ithaca, NY) and Center for EPR Imaging in In Vivo Physiology (University of Chicago, Chicago, IL). The EPR Group at the National Cancer Institute will also participate in the conference. The meeting is also likely to attract a significant number of participants from other countries in Latin America, Europe, Asia, Australia, and South America. It is important for the U.S. to be well-represented at this meeting, so that our NIH and other funded scientists can keep up with the latest technological developments from around the world and to establish future collaborations with potential investigators, postdoctoral fellows and graduate students.
PUBLIC HEALTH RELEVANCE: This is the first conference on in vivo spectroscopy, spin trapping, and spin labeling to be held in Puerto Rico. This interdisciplinary scientific conference will bring together physicians, chemists and biologist from the U.S. and around the globe, who are engaged in research activities involving magnetic resonance, structural and redox biology, radiation, cancer, and other rare diseases. The major purpose of this meeting is to discuss the applications of state-of-the-art EPR methodology in biomedical research with a view to enlightening the younger faculty, postdoctoral fellows and graduate students on the broad scope of activities in magnetic resonance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
-
批准号:9763831
-
项目类别:
-
资助金额:$37.89万
-
财政年份:2019
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
-
批准号:9915863
-
项目类别:
-
资助金额:$38.21万
-
财政年份:2019
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
-
批准号:10489835
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2019
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
-
批准号:10687020
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2019
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
-
批准号:10476701
-
项目类别:
-
资助金额:$42.26万
-
财政年份:2019
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Chemoprevention of Lung Cancer with Mitochondria-Targeted Honokiol
-
批准号:10497449
-
项目类别:
-
资助金额:$52.37万
-
财政年份:2017
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Chemoprevention of lung cancer with mitochondria-targeted honokiol
-
批准号:10092125
-
项目类别:
-
资助金额:$11.51万
-
财政年份:2017
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Mitochondria-targeted Agents in Breast Cancer
-
批准号:8453421
-
项目类别:
-
资助金额:$28.76万
-
财政年份:2010
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Mitochondria-targeted Agents in Breast Cancer
-
批准号:8271285
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2010
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Mitochondria-targeted Agents in Breast Cancer
-
批准号:8089425
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2010
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:7531598
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:7934163
-
项目类别:
-
资助金额:$8.51万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:8074198
-
项目类别:
-
资助金额:$8.51万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:8268535
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:8077923
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:7645854
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells
-
批准号:7849003
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Peroxide, NO and Iron Signaling in Endothelial Damage
-
批准号:6850673
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2003
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Peroxide, NO and Iron Signaling in Endothelial Damage
-
批准号:6600276
-
项目类别:
-
资助金额:$28.75万
-
财政年份:2003
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
Peroxide, NO and Iron Signaling in Endothelial Damage
-
批准号:6721393
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2003
-
负责人:BALARAMAN KALYANARAMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
烟粉虱AsiaⅡ7和MED隐种对CLCuMuV的自噬作用及其分子机制
-
批准号:32001973
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:陈婷
-
依托单位:
烟粉虱AsiaⅡ7和MED隐种中肠在传播双生病毒差异性中的分子机制
-
批准号:2020A151501098
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2020
-
负责人:陈婷
-
依托单位:
Asia Ⅱ7和MEAM1烟粉虱传播木尔坦棉花曲叶病毒能力差异的分子机理
-
批准号:31871937
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:何自福
-
依托单位:
Asia1型口蹄疫病毒RGD基序突变株识别受体的鉴定和比较
-
批准号:31302118
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2013
-
负责人:郑海学
-
依托单位:
紫云英二磷酸核苷磷酸酯酶AsIA257在共生固氮过程中的功能研究
-
批准号:31000115
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:李一星
-
依托单位:
口蹄疫Asia-I型病毒VP1和3D基因在山羊痘病毒共表达关系的研究
-
批准号:30760181
-
项目类别:地区科学基金项目
-
资助金额:17.0万元
-
批准年份:2007
-
负责人:马文戈
-
依托单位: